2004-2008, Quantum Laboratories, Inc.. All rights reserved.

 

 

Panic Disorders in Adolescents


Protocol A6131002: A Randomized, double blind, placebo-controlled study of Xanax XR in the treatment of adolescents with a primary diagnosis of Panic Disorder.


Protocol A 6131004: An open label study to asses the safety and tolerance of Xanax XR in the treatment of adolescents with panic disorder or anxiety with panic attacks.

Protocol A6131007: A Randomized, double blind, placebo-controlled study of continuation treatment with Xanax XR in the treatment of adolescents with a primary diagnosis of Panic Disorder.


For more information please call (561) 687-2111

 

 


Our facility identifies and recruits appropriate patients and monitors them during the study. If you qualify and consent to participate, there will be no charge for your study medication and office visits. Additionally, you are responsible for attendence to regular scheduled appointments.


Fact:

During any one-year period, up to 50 million Americans suffer from clearly diagnosable mental disorder involving a degree of incapacity that interferes with employment, attendence at school or daily life.